Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • Immunology/Inflammation related
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

rg-7593, dcdt2980s, dcdt-2989s

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
Pinatuzumab vedotin
RG-7593, DCDT-2989S, DCDT2980S, anti-CD22-vc-MMAE
T9901A-0291313706-14-7
Pinatuzumab vedotin is an antibody-drug conjugate (ADC) formed by conjugating the humanized anti-CD22 monoclonal antibody pinatuzumab with VcMMAE, and exhibits antitumor activity.
  • $413
2-4 weeks
Size
QTY